Founded Year



Incubator/Accelerator - III | Alive

Total Raised


About Feebris

Feebris is a mobile health platform, powered by AI, that enables non-medical users to diagnose and monitor complex health conditions in the community.

Feebris Headquarter Location

Accelerator London 35 Kingsland Road

London, England, E2 8AA,

United Kingdom

Feebris's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Feebris's Products & Differentiation

See Feebris's products and how their products differentiate from alternatives and competitors

  • Feebris

    The core of our AI-powered platform is the proprietary AI-guided examination & triage engine, which translates data from off-the-shelf point-of-care sensors into reliable and actionable clinical insights. The platform has three major components: Mobile App: connects wirelessly to medical sensors (e.g. pulse oximeters, digital stethoscopes) and guides a non-clinical user through AI algorithms for quality control, symptom extraction, and deterioration triage. Clinical Web Portal: clinical teams review, prioritize, and distribute deterioration response, accelerating treatment access. Population Health Management Web Portal: population health teams review insights informing resource allocation and risk management.


    Clinical reliability - Remote measurements are often of poor quality, leading to wasted clinician time. Feebris AI-powered platform ensures clinical reliability of measurement collection and output. 

    Health equity by design - Rural and underserved communities may not have adequate connectivity for remote monitoring. With Feebris, a care worker can conduct clinical grade examinations and receive … 

    Workforce enhancement - Feebris augments existing and enables new models of decentralized healthcare delivery. 

    Proven ROI - Feebris is backed by real world evidence of economic return on investment for values-based care, including reductions in unnecessary ER visits and hospitalizations, as well as shorter t… 

Expert Collections containing Feebris

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Feebris is included in 6 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,451 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,839 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health Monitoring & Diagnostics

838 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics


Health IT

8,876 items

Latest Feebris News

Discussing Diversity: Being the first black NIA fellow – a source of comfort or concern?

Jul 1, 2021

Sami Nur, Director of Strategic Development and Partnership at Feebris and Digital Health Specialist, shares his reflections on navigating his roles in the NHS and health tech as a person of colour. Feebris is a DigitalHealth.London Accelerator company and Sami was selected as an NHS Innovation Accelerator (NIA) Fellow in 2021. Just six months intoRead more The post Discussing Diversity: Being the first black NIA fellow – a source of comfort or concern? appeared first on NIA.

Feebris Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Feebris Rank

  • When was Feebris founded?

    Feebris was founded in 2017.

  • Where is Feebris's headquarters?

    Feebris's headquarters is located at Accelerator London, London.

  • What is Feebris's latest funding round?

    Feebris's latest funding round is Incubator/Accelerator - III.

  • How much did Feebris raise?

    Feebris raised a total of $80K.

  • Who are the investors of Feebris?

    Investors of Feebris include NHS Innovation Accelerator, Digital Health London, Social Starts, TechForce19, 24Haymarket and 5 more.

  • Who are Feebris's competitors?

    Competitors of Feebris include Current Health and 3 more.

  • What products does Feebris offer?

    Feebris's products include Feebris.

  • Who are Feebris's customers?

    Customers of Feebris include Northumbria Foundation Trust and North East London CCG.

You May Also Like

Myia Health

Myia provides a platform for optimizing virtual healthcare delivery through Remote Patient Monitoring, predictive analytics, process control, and workflow orchestration. The platform ingests a wide range of real-world data from curated sensors and sources, transforming it through applied machine intelligence into objective clinical insights. Harnessing the power of human data, Myia equips clinicians with the precise information they need to both optimize care and prevent unplanned events.

Sensome Logo

Sensome develops micro-sensor technology for smart medical devices. Sensome's sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.

Glooko Logo

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

Intelligent Implants

Intelligent Implants is developing electrotherapeutic devices to treat disease and aid recovery in bone and other tissues. The company uses data, engineering, and biologics to bring new, active and connected medical devices to healthcare. These integrated devices facilitate treatment for the patient, as well as, decision making for the healthcare professional.

Ultromics Logo

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

EarLens Logo

EarLens provides hearing aids, which use light and a small lens placed on the user's eardrum to directly activate their natural hearing system. It was founded in 2005 and is based in Menlo Park, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.